JCN Newswire
TOKYO, July 14, 2025 – (JCN Newswire) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has launched “URECE®” (brand name in China: “Youlesi®”, generic name: dotinurad) in China as a treatment for Gout. URECE was approved by the National Medical Products Administration in China as a treatment for gout patients with hyperuricemia in December 2024.URECE is a new therapeutic medicine for gout and hyperuricemia discovered by FUJI YAKUHIN…
Read More
“URECE” (Dotinurad) Launched in China as a treatment for Gout
Raleigh Kucera
04:22
TOKYO, July 14, 2025 – (JCN Newswire) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has launched “URECE®” (brand name in China: “Youlesi®”, generic name: dotinurad) in China as a treatment for Gout. URECE was approved by the National Medical Products Administration in China as a treatment for gout
